510(k) device
Evis Exera III Bronchovideoscope (Olympus BF-Q190)
Olympus Medical Systems Corp. · Bronchoscope (Flexible Or Rigid) (EOQ, Class II) · First FDA decision Jan 10, 2013, newest Apr 23, 2026Lung cancer and lung nodules
Last checked: Nov 21, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
6
510(k) pathway
Device trials
7
Naming "Evis Exera III"
MAUDE reports
91,263
Brand "Evis Exera III", since 2015
PubMed studies
6
Mentioning "Evis Exera III"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Evis Exera III Bronchovideoscope (Olympus BF-Q190)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 6 decisions filed under this name.
K252341 · Decided Apr 23, 2026 · 269 days after receipt
Device type: Bronchoscope (Flexible Or Rigid) (EOQ) · Otolaryngology (ENT)
5 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Evis Exera III", any status and sponsor, newest update first.
- Comparisons of Endo-Wing-assisted Colonoscopy Versus Standard Colonoscopy in Improving Adenoma Detection Rate in Symptomatic Patients Suspected of Colorectal CancerPivotal-lookingCompleted
Universiti Kebangsaan Malaysia Medical CentreAcademic, hospital or other
NCT06859125 · 192 participants · Start Sep 1, 2019 · Primary completion Apr 30, 2020
Device: Endo-Wing™ (Shangxian Minimal Invasive Inc, China); Standard Colonoscopy · For: Colorectal Adenoma
Sites: Cheras, Malaysia
6 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Evis Exera III", and for the whole product code for context.
This brand
91,263 reports: 89,479 malfunction, 1,720 injury, 61 death
Whole product code EOQ
33,033 reports: 28,729 malfunction, 4,104 injury, 190 death
Newest reports for this brand
- EVIS EXERA III COLONOVIDEOSCOPEMalfunction
9610595-2026-88175 · Received Oct 30, 2026
Device type: Colonoscope And Accessories, Flexible/Rigid (FDF)
Device problem as coded: Poor Quality Image
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- BRONCHOVIDEOSCOPE OLYMPUS BF-1TH1100Open, Classified
Olympus Corporation of the Americas
Z-0048-2026 · Started Sep 11, 2025 · Posted by FDA Oct 16, 2025
Reason given: Additional IFU updates to provide further clarification on safe and effective use of bronchoscopes when used in conjunction with laser, argon plasma coagulation, and high-frequency therapy equipment.
Cause as FDA categorized it: Device Design · Device type: Bronchoscope (Flexible Or Rigid) (EOQ)
21 more recall records with a free account
Published research
The most relevant PubMed records for "Evis Exera III"[tiab]. The summary above synthesizes these.
- A Change in Scope: Endoscopic Retrograde Cholangiopancreatography via a Gastroscope in Billroth II Gastrojejunostomy.
Vudayagiri L, Markle HL, Wood D, et al. · Cureus · 2023Case Reports
- Panoramic colonoscopy in colorectal cancer screening - a randomized controlled trial.
Bogacki P, Gach T, Krzak J, et al. · Wideochir Inne Tech Maloinwazyjne · 2021
- Narrow-band imaging features of oral lichenoid conditions: A multicentre retrospective study.
Guida A, Ionna F, Farah CS · Oral Dis · 2023Multicenter Study
- Usefulness of Non-magnifying Narrow Band Imaging in EVIS EXERA III Video Systems and High-Definition Endoscopes to Diagnose Dysplasia in Barrett's Esophagus Using the Barrett International NBI Group (BING) Classification.
Nogales O, Caballero-Marcos A, Clemente-Sánchez A, et al. · Dig Dis Sci · 2017Evaluation Study
- Cameron Lesions: Endoscopic Characteristics, Clinical Profile, and Therapeutic Implications-A Retrospective Study of 43 Patients.
Istrate V, Moraru AC, Ungureanu S, et al. · Diagnostics (Basel) · 2026
- Influence of Simethicone Added to the Rinse Water during Colonoscopies on Polyp Detection Rates: Results of an Unintended Cohort Study.
Kutyla M, O'Connor S, Gurusamy SR, et al. · Digestion · 2018
Other devices of this type
Also filed under product code EOQ.
- Ion Endoluminal System (IF1000)Intuitive Surgical, Inc. · 510(k) 2025
- Ambu® aScope 5 Broncho 2.7/1.2Ambu A/S · 510(k) 2026
- MONARCH Platform (MON-000008)Auris Health, Inc. · 510(k) 2026
- Vathin® Video Bronchoscope SystemHunan Vathin Medical Instrument Co., Ltd. · 510(k) 2025
- FUJIFILM Endoscope Model EB-840SFujifilm Corporation · 510(k) 2026
- Broncho Videoscope System (Single-use Broncho Videoscope (SBV-1A-BScivita Medical Technology Co., Ltd. · 510(k) 2025
- Single-use Flexible BronchoscopeHunan Vathin Medical Instrument Co., Ltd. · 510(k) 2026
- LoopView® Single-Use Digital Flexible Bronchoscope (B27-C, B27-CG)MacroLux Medical Technology Co., Ltd. · 510(k) 2026
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.